News Breaks |
|
|
| December 11, 2012 |
| 07:54 EDT |  | ALKS, PRXL, MEDI, TEVA, NPSP, CELG, AZN, ACOR, PFE | Elsevier Business Intelligence to host a summit
The FDA/CMS Summit for Biopharma Executives: Life After 2012 is being held in Washington, D.C. on December 10-11. |
|
|
News For MEDI;PFE;CELG;PRXL;ACOR;NPSP;ALKS;AZN;TEVA From The Last 14 Days Check below for free stories on MEDI;PFE;CELG;PRXL;ACOR;NPSP;ALKS;AZN;TEVA the last two weeks. |
|
|
| June 19, 2013 |
| 17:52 EDT |  | PFE | Pfizer announces final exchange ratio for Zoetis exchange offer
 Subscribe for More Information |
|
| 16:01 EDT |  | PFE | Options Update; June 19, 2013
Subscribe for More Information |
|
| 14:04 EDT | | PRXL | PAREXEL to host investor day
Subscribe for More Information |
|
| 11:23 EDT |  | TEVA | Teva added to short-term buy list at Deutsche Bank
|
|
| 10:30 EDT | | PFE | Pfizer management to meet with ISI Group
Subscribe for More Information |
|
| 10:01 EDT |  | TEVA | On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Coca-Cola (KO) initiated with an Outperform at Credit Suisse... Dr Pepper Snapple (DPS) initiated with a Neutral at Credit Suisse... Keryx (KERX) initiated with an Overweight at JPMorgan... Neurocrine Biosciences (NBIX) initiated with an Outperform at Oppenheimer... PepsiCo (PEP) initiated with a Neutral at Credit Suisse... Superior Energy (SPN) initiated with an Outperform at Cowen... Chambers Street Properties (CSG) initiated with a Neutral at Ladenburg... Synergy Resources (SYRG) initiated with an Outperform at Iberia... Callidus Software (CALD) initiated with a Buy at Lake Street... Teva (TEVA) initiated with a Buy at Maxim... Ubiquiti Networks (UBNT) initiated with an Outperform at JMP Securities... Vantiv (VNTV) initiated with an Overweight at Morgan Stanley... Visa (V) initiated with an Overweight at Morgan Stanley... MasterCard (MA) initiated with an Overweight at Morgan Stanley... Global Payments (GPN) initiated with an Underweight at Morgan Stanley... Green Dot (GDOT) initiated with an Underweight at Morgan Stanley... Total System (TSS) initiated with an Equal Weight at Morgan Stanley... MoneyGram (MGI) initiated with an Equal Weight at Morgan Stanley... Heartland Payment (HPY) initiated with an Equal Weight at Morgan Stanley... FleetCor (FLT) initiated with an Equal Weight at Morgan Stanley... Western Union (WU) initiated with an Equal Weight at Morgan Stanley... CorEnergy (CORR) initiated with an Outperform at Wells Fargo. |
|
| 08:02 EDT | | TEVA | Teva initiated with a Buy at Maxim
Subscribe for More Information |
|
| 07:44 EDT | | TEVA | Teva initiated with a Buy at Maxim
Target $56. |
|
| 07:41 EDT | | PFE | Pfizer holders should consider Zoetis exchange, says BMO Capital
BMO Capital thinks Pfizer (PFE) investors should consider participating in the Zoetis (ZTS) exchange as they have the opportunity to own Zoetis at around $29.40-$29.70 per share, which is 15% below BMO's valuation of $34 per share. Further, BMO thinks there is strong support for Zoetis below $30, which the firm feels lowers downside risk. BMO recommends that Pfizer investors tender around 20% of their shares into the exchange, noting that with the offer likely being oversubscribed, not all tendered shares will be converted to Zoetis. |
|
| 06:11 EDT |  | TEVA | Teva settles lawsuit, agrees to specify executive pay, Bloomberg reports
Subscribe for More Information |
| |
| 05:43 EDT | | AZN | AstraZeneca, Bristol-Myers announce top line results of Phase 4 trial of Onglyza
Subscribe for More Information |
|
| June 18, 2013 |
| 12:32 EDT | | AZN | AstraZeneca CEO says turnaround to take three or four years, Reuters reports
It will likely take three or four years for AstraZeneca's turnaround efforts to bear fruit, the company's CEO, Pascal Soriot, said today, according to Reuters. Reference Link |
|
| 09:38 EDT | | PFE | Active equity option families trading on open
Active equity option families trading on open according to Track Data: AAPL NFLX GOOG PFE TSLA MGM |
|
| 08:37 EDT | | AZN | Drug companies turn to microchips to test medicines, WSJ reports
Subscribe for More Information |
|
| 07:22 EDT | | AZN | Citigroup to host a conference
Subscribe for More Information |
|
| June 17, 2013 |
| 16:00 EDT | | PFE | Options Update; June 17, 2013
Subscribe for More Information |
|
| 13:20 EDT | | TEVA | Supreme Court rules generic drug makers can be sued over 'pay to delay'
Subscribe for More Information |
|
| 11:54 EDT | | TEVA | Supreme Court ruling a modest negative for generics, says Leerink
Subscribe for More Information |
|
| 09:31 EDT | | TEVA | Teva acquires MicroDose Therapeutx
Subscribe for More Information |
|
| 08:36 EDT | | PFE | InSite Vision to join Merck, Pfizer patent suit against Mylan
InSite Vision (INSV) announced that it will join Merck (MRK) and Pfizer (PFE) in filing a patent infringement lawsuit against Mylan Pharmaceuticals (MYL). Mylan recently filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking to market a generic version of AzaSite before expiration of the patents covering AzaSite and its use. AzaSite is marketed by Merck in the U.S. On May 26, 2011, InSite and Merck filed a similar patent infringement lawsuit against Sandoz. A trial date for the Sandoz ANDA suit has been set for July 11, 2013. The companies have agreed that Merck will take the lead in prosecuting both lawsuits. Each company will be responsible for their own legal costs, with InSite assuming a monitoring role, the company said. |
| |
|
|
|
|
